TY - JOUR AU - Kohler, D. R. AU - Montello, M. J. AU - Green, L. AU - Huntley, C. AU - High, J. L. AU - Fallavollita, A. AU - Goldspiel, B. R. PY - 1998 DA - 1998// TI - Standardizing the expression and nomenclature of cancer treatment regimens. American Society of Health-System Pharmacist (ASHP), American Medical Association (AMA), American Nurses Association (ANA) JO - Am J Health Syst Pharm VL - 55 ID - Kohler1998 ER - TY - JOUR AU - Cohen, M. R. AU - Anderson, R. W. AU - Attilio, R. M. AU - Green, L. AU - Muller, R. J. AU - Pruemer, J. M. PY - 1996 DA - 1996// TI - Preventing medication errors in cancer chemotherapy JO - Am J Health Syst Pharm VL - 53 ID - Cohen1996 ER - TY - JOUR AU - Pedersen, C. A. AU - Schneider, P. J. AU - Scheckelhoff, D. J. PY - 2007 DA - 2007// TI - SHP national survey of pharmacy practice in hospital settings: monitoring and patient education-2006 JO - Am J Health Syst Pharm VL - 64 UR - https://doi.org/10.2146/ajhp060669 DO - 10.2146/ajhp060669 ID - Pedersen2007 ER - TY - JOUR AU - Manias, E. AU - Williams, A. AU - Liew, D. PY - 2012 DA - 2012// TI - Interventions to reduce medication errors in adult intensive care: a systematic review JO - Br J Clin Pharmacol VL - 74 UR - https://doi.org/10.1111/j.1365-2125.2012.04220.x DO - 10.1111/j.1365-2125.2012.04220.x ID - Manias2012 ER - TY - JOUR AU - Sánchez Ulayar, A. AU - Gallardo López, S. AU - Pons Llobet, N. AU - Murgadella Sancho, A. AU - Campins Bernadàs, L. AU - Merino Méndez, R. PY - 2012 DA - 2012// TI - Pharmaceutical intervention upon hospital discharge to strengthen understanding and adherence to pharmacological treatment JO - Farm Hosp VL - 36 UR - https://doi.org/10.1016/j.farma.2011.02.003 DO - 10.1016/j.farma.2011.02.003 ID - Sánchez Ulayar2012 ER - TY - JOUR AU - Dranitsaris, G. AU - Warr, D. AU - Puodziunas, A. PY - 1995 DA - 1995// TI - A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron JO - Support Care Cancer VL - 3 UR - https://doi.org/10.1007/BF00368888 DO - 10.1007/BF00368888 ID - Dranitsaris1995 ER - TY - JOUR AU - Skipper, H. E. AU - Schabel, F. M. AU - Wilcox, W. S. PY - 1964 DA - 1964// TI - Experimental evaluation of potential anticancer agents. XII. On the criteria and kinetics associated with curability of experimental leukemia JO - Cancer Chemother Rep VL - 35 ID - Skipper1964 ER - TY - JOUR AU - Skipper, H. E. AU - Schabel, F. M. AU - Wilcox, W. S. PY - 1965 DA - 1965// TI - Experimental evaluation of potential anticancer agents. XIV. Further studies on certain basic concepts underlying chemotherapy of leukemia JO - Cancer Chemother Rep VL - 45 ID - Skipper1965 ER - TY - JOUR AU - Skipper, H. E. AU - Schabel, F. M. AU - Wilcox, W. S. PY - 1967 DA - 1967// TI - Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells JO - Cancer Chemother Rep VL - 51 ID - Skipper1967 ER - TY - JOUR AU - Hasenclever, D. AU - Brosteanu, O. AU - Gerike, T. AU - Loeffler, M. PY - 2001 DA - 2001// TI - Modelling of chemotherapy: the effective dose approach JO - Ann Hematol VL - 80 ID - Hasenclever2001 ER - TY - JOUR AU - Goldie, J. H. AU - Coldman, A. J. PY - 1979 DA - 1979// TI - A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate JO - Cancer Treat Rep VL - 63 ID - Goldie1979 ER - TY - JOUR AU - Bonadonna, G. AU - Valagussa, P. AU - Moliterni, A. AU - Zambetti, M. AU - Brambilla, C. PY - 1995 DA - 1995// TI - Adjuvant cyclophosphamide, methotrexate, and fluorouracil in nodepositive breast cancer: the results of 20 years of follow-up JO - N Engl J Med VL - 332 UR - https://doi.org/10.1056/NEJM199504063321401 DO - 10.1056/NEJM199504063321401 ID - Bonadonna1995 ER - TY - JOUR AU - Hans, W. AU - Marcel, R. PY - 2011 DA - 2011// TI - Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma JO - Crit Rev Oncol Hematol VL - 77 UR - https://doi.org/10.1016/j.critrevonc.2010.02.002 DO - 10.1016/j.critrevonc.2010.02.002 ID - Hans2011 ER - TY - JOUR AU - Ozer, H. AU - Armitage, J. O. AU - Bennett, C. L. AU - Crawford, J. AU - Demetri, G. D. AU - Pizzo, P. A. AU - Schiffer, C. A. AU - Smith, T. J. AU - Somlo, G. AU - Wade, J. C. AU - Wade, J. L. AU - Winn, R. J. AU - Wozniak, A. J. AU - Somerfield, M. R. PY - 2000 DA - 2000// TI - 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel JO - J Clin Oncol VL - 18 ID - Ozer2000 ER - TY - JOUR AU - Fossella, F. V. 1. AU - DeVore, R. AU - Kerr, R. N. AU - Crawford, J. AU - Natale, R. R. AU - Dunphy, F. AU - Kalman, L. AU - Miller, V. AU - Lee, J. S. AU - Moore, M. AU - Gandara, D. AU - Karp, D. AU - Vokes, E. AU - Kris, M. AU - Kim, Y. AU - Gamza, F. AU - Hammershaimb, L. PY - 2000 DA - 2000// TI - Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group JO - J Clin Oncol VL - 18 ID - Fossella2000 ER - TY - JOUR AU - Burris, H. A. AU - Moore, M. J. AU - Andersen, J. AU - Green, M. R. AU - Rothenberg, M. L. AU - Modiano, M. R. AU - Cripps, M. C. AU - Portenoy, R. K. AU - Storniolo, A. M. AU - Tarassoff, P. AU - Nelson, R. AU - Dorr, F. A. AU - Stephens, C. D. AU - Hoff, D. D. PY - 1997 DA - 1997// TI - Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial JO - J Clin Oncol VL - 15 ID - Burris1997 ER - TY - JOUR AU - Moore, J. M. AU - Shartle, D. AU - Faudskar, L. AU - Matlin, O. S. AU - Brennan, T. A. PY - 2013 DA - 2013// TI - Impact of a patient-centered pharmacy program and intervention in a high-risk group JO - J Manag Care Pharm VL - 19 ID - Moore2013 ER - TY - JOUR AU - Yu, J. AU - Shah, B. M. AU - Ip, E. J. AU - Chan, J. PY - 2013 DA - 2013// TI - A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California JO - J Manag Care Pharm VL - 19 ID - Yu2013 ER - TY - JOUR AU - Sibylle, L. AU - Tomas, S. AU - Valentina, N. AU - Hans, J. L. AU - Matthias, S. AU - Thomas AU - Christoph, Z. AU - Gunter, M. PY - 2011 DA - 2011// TI - Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis JO - BMC Cancer VL - 11 UR - https://doi.org/10.1186/1471-2407-11-131 DO - 10.1186/1471-2407-11-131 ID - Sibylle2011 ER -